124 related articles for article (PubMed ID: 30142729)
1. A glimpse into the underground market of melanotan.
Callaghan Iii DJ
Dermatol Online J; 2018 May; 24(5):. PubMed ID: 30142729
[TBL] [Abstract][Full Text] [Related]
2. [The Barbie drug melanotan--new internet drug with risky consequences].
Knudsen K; Kjergaard C; Dalhoff K
Lakartidningen; 2012 Oct 17-23; 109(42):1895-6. PubMed ID: 23193937
[No Abstract] [Full Text] [Related]
3. Melanotan II injection resulting in systemic toxicity and rhabdomyolysis.
Nelson ME; Bryant SM; Aks SE
Clin Toxicol (Phila); 2012 Dec; 50(10):1169-73. PubMed ID: 23121206
[TBL] [Abstract][Full Text] [Related]
4. An in-depth case examination of an exotic dancer's experience of melanotan.
Van Hout MC; Brennan R
Int J Drug Policy; 2014 May; 25(3):444-50. PubMed ID: 24280586
[TBL] [Abstract][Full Text] [Related]
5. Risks of unregulated use of alpha-melanocyte-stimulating hormone analogues: a review.
Habbema L; Halk AB; Neumann M; Bergman W
Int J Dermatol; 2017 Oct; 56(10):975-980. PubMed ID: 28266027
[TBL] [Abstract][Full Text] [Related]
6. Use of melanotan I and II in the general population.
Evans-Brown M; Dawson RT; Chandler M; McVeigh J
BMJ; 2009 Feb; 338():b566. PubMed ID: 19224885
[No Abstract] [Full Text] [Related]
7. Eruptive naevi and darkening of pre-existing naevi 24 h after a single mono-dose injection of melanotan II.
Schulze F; Erdmann H; Hardkop LH; Anemüller W; Rose C; Zillikens D; Fischer TW
Eur J Dermatol; 2014; 24(1):107-9. PubMed ID: 24334249
[No Abstract] [Full Text] [Related]
8. Atypical melanocytic naevi following melanotan injection.
Reid C; Fitzgerald T; Fabre A; Kirby B
Ir Med J; 2013 May; 106(5):148-9. PubMed ID: 23914578
[TBL] [Abstract][Full Text] [Related]
9. [Melanotan-induced lentigines and nevi].
Thestrup-Pedersen K; Søndergaard K
Ugeskr Laeger; 2011 Mar; 173(13):975. PubMed ID: 21453640
[TBL] [Abstract][Full Text] [Related]
10. Melanotan II User Experience: A Qualitative Study of Online Discussion Forums.
Gilhooley E; Daly S; McKenna D
Dermatology; 2021; 237(6):995-999. PubMed ID: 34464955
[TBL] [Abstract][Full Text] [Related]
11. The unregulated use of melanotan-II is of public health interest to Australian dermatologists.
Adler NR; Dowling JP; Pan Y
Australas J Dermatol; 2017 Nov; 58(4):327-329. PubMed ID: 28905366
[No Abstract] [Full Text] [Related]
12. Melanotan and the posterior reversible encephalopathy syndrome.
Kaski D; Stafford N; Mehta A; Jenkins IH; Malhotra P
Ann Intern Med; 2013 May; 158(9):707-8. PubMed ID: 23648958
[No Abstract] [Full Text] [Related]
13. Melanotropic peptides: more than just 'Barbie drugs' and 'sun-tan jabs'?
Langan EA; Nie Z; Rhodes LE
Br J Dermatol; 2010 Sep; 163(3):451-5. PubMed ID: 20545686
[TBL] [Abstract][Full Text] [Related]
14. [Eruptive nevi after injection of drugs marketed as melanotan II. The first two Swedish cases described].
Burian E; Burian E
Lakartidningen; 2013 Jan 30-Feb 5; 110(5):208-10. PubMed ID: 23451671
[No Abstract] [Full Text] [Related]
15. Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study.
Wessells H; Fuciarelli K; Hansen J; Hadley ME; Hruby VJ; Dorr R; Levine N
J Urol; 1998 Aug; 160(2):389-93. PubMed ID: 9679884
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization by LC-UV-MS/MS of melanotan II skin-tanning products sold illegally on the Internet.
Breindahl T; Evans-Brown M; Hindersson P; McVeigh J; Bellis M; Stensballe A; Kimergård A
Drug Test Anal; 2015 Feb; 7(2):164-72. PubMed ID: 24771717
[TBL] [Abstract][Full Text] [Related]
17. Melanoma associated with the use of melanotan-II.
Hjuler KF; Lorentzen HF
Dermatology; 2014; 228(1):34-6. PubMed ID: 24355990
[TBL] [Abstract][Full Text] [Related]
18. Systemic photoprotection in solar urticaria with α-melanocyte-stimulating hormone analogue [Nle4-D-Phe7]-α-MSH.
Haylett AK; Nie Z; Brownrigg M; Taylor R; Rhodes LE
Br J Dermatol; 2011 Feb; 164(2):407-14. PubMed ID: 20969564
[TBL] [Abstract][Full Text] [Related]
19. Melanotan-II: Investigation of the inducer and facilitator effects on penile erection in anaesthetized rat.
Giuliano F; Clément P; Droupy S; Alexandre L; Bernabé J
Neuroscience; 2006; 138(1):293-301. PubMed ID: 16360286
[TBL] [Abstract][Full Text] [Related]
20. Melanotan II: a possible cause of renal infarction: review of the literature and case report.
Peters B; Hadimeri H; Wahlberg R; Afghahi H
CEN Case Rep; 2020 May; 9(2):159-161. PubMed ID: 31953620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
